Reimbursement & Market Access Solutions

Coverage, coding, evidence, and payment must be defined before U.S. adoption

A complete reimbursement and market access strategy is required for MedTech companies entering the U.S. market. Every technology must establish a viable path to coverage, coding, and payment, supported by evidence that meets payer, hospital, and provider expectations. The earliest reimbursement decisions occur during clinical trials and influence trial economics, operational readiness, and downstream commercial adoption.

Our team integrates clinical, regulatory, and commercial requirements to create an aligned reimbursement foundation for early use and long-term access.

Expected Outcomes

What You'll Achieve

A defined path for coverage, coding, and payment

Evidence aligned with payer and hospital requirements

Clear incentives for providers across inpatient and outpatient environments

Predictable financial planning during clinical trials

Infrastructure for accurate billing and field-level adoption

Integration of reimbursement with clinical, regulatory, and commercial planning

What We Offer

Our Reimbursement & Market Access Services

Determining CPT or HCPCS coding pathways

Evaluating crosswalk and valuation options

Assessing coverage rules across Medicare, Medicaid, and commercial plans

Coding & Coverage Strategy

Coding and coverage decisions determine how a technology enters the U.S. payment system. These choices shape hospital economics, physician adoption, payer acceptance, and the feasibility of long-term reimbursement.

DRG, APC, ASC, and physician payment models

Packaging, bundling, and pass-through implications

Site-of-service economic differentials

Site of Service Reimbursement Pathways

Reimbursement rules vary across inpatient, outpatient, and physician settings. Understanding site-of-care economics aligns utilization, provider incentives, and commercialization strategy across the continuum of care.

DRG, APC, ASC, and physician payment models

Packaging, bundling, and pass-through implications

Site-of-service economic differentials

Medicare coverage analysis for device trials

Billing grids defining routine care versus sponsor obligations

Billing pathways for feasibility, early feasibility, and pivotal trials

Reimbursement During a Clinical Trial

Clear reimbursement planning during clinical trials determines whether sites can bill for routine care. Proper structure reduces sponsor financial exposure, accelerates site activation, and supports compliant enrollment across study phases.

Outcomes aligned to payer medical policies

Cost-offset and health economic modeling

Evidence packages for value analysis committees

Value Analysis & Payer Evidence

Hospitals and payers require evidence that demonstrates clinical relevance and economic value. Value analysis and payer evidence planning shape purchasing decisions, coverage outcomes, and provider adoption.

Outcomes aligned to payer medical policies

Cost-offset and health economic modeling

Evidence packages for value analysis committees

NTAP and TCET eligibility

Payment impact under DRG and APC systems

Operational and economic implications for providers

New Technology Payment Strategy

Transitional CMS payment pathways such as NTAP and TCET can support early hospital adoption. Evaluating eligibility and evidence requirements helps bridge reimbursement gaps while permanent payment pathways mature.

Scalable field team models that support commercial growth

Claim preparation and appeals

Prior authorization and medical necessity guidance

Field Reimbursement Operations

Ongoing field reimbursement support helps providers navigate billing, coding, and payer requirements. This infrastructure reduces friction at the point of care and enables scalable commercial adoption.

Scalable field team models that support commercial growth

Claim preparation and appeals

Prior authorization and medical necessity guidance

Ready to Get Started?

Let’s discuss how our reimbursement & market access expertise can accelerate your path to market